Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database

BACKGROUND: Costs associated with biologic switching and discontinuation can be high in psoriatic arthritis (PsA), and their inappropriate use may have cost implications for patients, healthcare professionals, and payers. OBJECTIVE: To compare direct costs of treatment switchers, non-switchers, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Peter, Kim, Nina, Dai, Dong, Piao, Olivia W., Zheng, Josh Z., Yi, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984152/
https://www.ncbi.nlm.nih.gov/pubmed/33179146
http://dx.doi.org/10.1007/s40801-020-00217-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984152/
https://www.ncbi.nlm.nih.gov/pubmed/33179146
http://dx.doi.org/10.1007/s40801-020-00217-4

Ejemplares similares